AEGLEA BIOTHERAPEUTICS INC's ticker is AGLE and the CUSIP is 00773J103. A total of 32 filers reported holding AEGLEA BIOTHERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.4%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $10,217 | +44.3% | 35,230 | +123.4% | 0.00% | – |
Q4 2022 | $7,081 | +18.0% | 15,770 | +35.1% | 0.00% | – |
Q3 2022 | $6,000 | +50.0% | 11,676 | +59.9% | 0.00% | – |
Q2 2022 | $4,000 | -90.2% | 7,301 | -59.5% | 0.00% | – |
Q1 2022 | $41,000 | -72.1% | 18,005 | -42.0% | 0.00% | – |
Q4 2021 | $147,000 | -27.9% | 31,067 | +21.2% | 0.00% | – |
Q3 2021 | $204,000 | +44.7% | 25,639 | +26.8% | 0.00% | – |
Q2 2021 | $141,000 | -55.1% | 20,216 | -49.1% | 0.00% | – |
Q1 2021 | $314,000 | +196.2% | 39,690 | +193.6% | 0.00% | – |
Q4 2020 | $106,000 | -69.8% | 13,517 | -72.7% | 0.00% | – |
Q3 2020 | $351,000 | +96.1% | 49,490 | +155.9% | 0.00% | – |
Q2 2020 | $179,000 | +184.1% | 19,337 | +44.0% | 0.00% | – |
Q1 2020 | $63,000 | -67.0% | 13,430 | -46.4% | 0.00% | – |
Q4 2019 | $191,000 | -10.7% | 25,041 | -10.1% | 0.00% | – |
Q3 2019 | $214,000 | +17.6% | 27,865 | +5.1% | 0.00% | – |
Q2 2019 | $182,000 | +64.0% | 26,510 | +93.7% | 0.00% | – |
Q1 2019 | $111,000 | -13.3% | 13,688 | -20.2% | 0.00% | – |
Q4 2018 | $128,000 | +212.2% | 17,145 | +299.9% | 0.00% | – |
Q3 2018 | $41,000 | +32.3% | 4,287 | +49.4% | 0.00% | – |
Q2 2018 | $31,000 | -58.1% | 2,870 | -61.4% | 0.00% | – |
Q1 2018 | $74,000 | +94.7% | 7,444 | +6.3% | 0.00% | – |
Q4 2017 | $38,000 | +8.6% | 7,000 | 0.0% | 0.00% | – |
Q3 2017 | $35,000 | +1066.7% | 7,000 | +1473.0% | 0.00% | – |
Q3 2016 | $3,000 | -25.0% | 445 | -47.3% | 0.00% | – |
Q2 2016 | $4,000 | – | 845 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Yu Fan | 112,044 | $532,000 | 6.17% |
Aisling Capital Management LP | 1,691,151 | $8,033,000 | 2.83% |
Bain Capital Life Sciences Investors, LLC | 2,847,689 | $13,527,000 | 1.07% |
GREAT POINT PARTNERS LLC | 910,251 | $4,324,000 | 0.96% |
Samsara BioCapital, LLC | 883,720 | $4,198,000 | 0.81% |
Sio Capital Management, LLC | 498,500 | $2,368,000 | 0.71% |
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 245,678 | $1,167,000 | 0.53% |
Nantahala Capital Management | 2,813,560 | $13,364,000 | 0.47% |
Altium Capital Management LP | 293,764 | $1,395,000 | 0.38% |
Lion Point Capital, LP | 300,000 | $1,425,000 | 0.38% |